- Lower volatility than the market (beta -0.17)
- Strong return on equity of 3,086.9%
- Highly efficient cash conversion (100% FCF/OCF ratio)
Weaker technical forecast for Diagnos Inc. as stock downgraded to Hold/Accumulate
(Updated on Jun 03, 2026)
The Diagnos Inc. stock price fell by -2.54% on the last day (Wednesday, 3rd Jun 2026) from $0.162 to $0.158. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 0% from a day low at $0.158 to a day high of $0.158. The price has fallen in 6 of the last 10 days but is still up by 9.6% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 5 thousand shares were bought and sold for approximately $788.00 .
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.165 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -32.25% during the next 3 months and, with a 90% probability hold a price between $0.0810 and $0.112 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
DGNOF Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, May 22, 2026, and so far it has risen 22.93%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Diagnos Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.162 and $0.160. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Diagnos Inc. stock
Diagnos Inc. finds support from accumulated volume at $0.157 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 6.75%.
Our recommended stop-loss: $0.152 (-3.78%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (DGNOF) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Diagnos Inc. to open at $0.158, and during the day (based on 14 day Average True Range), to move between $0.152 and $0.163, which gives a possible trading interval of +/-$0.0104 (+/-6.83%) up or down from last closing price. If Diagnos Inc. takes out the full calculated possible swing range there will be an estimated 6.83% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.157 (0.51%) than the resistance at $0.168 (6.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Diagnos Inc. stock A Buy?
Diagnos Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.
Current score:
0.226
Hold/Accumulate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $0.158 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
DGNOF Performance
Trading levels for DGNOF
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.158 | - |
| R2 | 0.158 | - |
| R1 | 0.158 | - |
| Price | 0.158 | |
| S1 | 0.158 | - |
| S2 | 0.158 | - |
| S3 | 0.158 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.193 | 22.56% |
| R2 | 0.189 | 19.92% |
| R1 | 0.168 | 6.79% |
| Price | 0.158 | |
| S1 | 0.157 | -0.508% |
| S2 | 0.156 | -1.02% |
| S3 | 0.144 | -8.63% |
FAQ
Click here for our free guide on how to buy Diagnos Inc. Stock.
Buy DGNOF